Use of an anti-CD200 antibody for prolonging the survival of allografts: a patent evaluation of WO2012106634A1.
about
Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials.The roles of myeloid-derived suppressor cells in transplantation.Addressing the Inflammatory Response to Clinically Relevant Polymers by Manipulating the Host Response Using ITIM Domain-Containing Receptors.Lung CD200 Receptor Activation Abrogates Airway Hyperresponsiveness in Experimental Asthma.
P2860
Use of an anti-CD200 antibody for prolonging the survival of allografts: a patent evaluation of WO2012106634A1.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Use of an anti-CD200 antibody ...... evaluation of WO2012106634A1.
@en
type
label
Use of an anti-CD200 antibody ...... evaluation of WO2012106634A1.
@en
prefLabel
Use of an anti-CD200 antibody ...... evaluation of WO2012106634A1.
@en
P2860
P1476
Use of an anti-CD200 antibody ...... evaluation of WO2012106634A1.
@en
P2093
Bart Luijk
Tomasz P Rygiel
P2860
P304
P356
10.1517/13543776.2013.765406
P407
P577
2013-01-28T00:00:00Z